CCR2 and lung cancer: A subsequent study demonstrated that inhibition of recruited macrophages by blockade of CCL2/CCR2 signaling did not attenuate lung cancer progression, as CCR2-deficient mice showed similar tumor growth rate compared to wild-type mice.